Saatja: Elen Ohov <
[email protected]>
Saadetud: 22.03.2019 18:41
Adressaat: SM Info <
[email protected]>
Teema: FW: Estonia: 2019 Country Survey on Capacity and Response to
Noncommunicable Diseases (NCD)
Peamiselt RTO vastutusvaldkonda jääv küsimustik.
Tervitades
Elen
From: EURO NCD Surveillance <
[email protected]> Sent: Friday,
March 22, 2019 3:13 PMTo: Elen Ohov <
[email protected]>Cc: REINAP, Marge
<
[email protected]>; EURO WHO Office in Estonia <
[email protected]>;
RAKOVAC, Ivo <
[email protected]>; MIKKELSEN, Bente <
[email protected]>;
JORGENSEN, Elena <
[email protected]>Subject: Estonia: 2019 Country
Survey on Capacity and Response to Noncommunicable Diseases (NCD)
Sent on behalf of Dr Bente Mikkelsen, Director, Division of
Noncommunicable Diseases and Promoting Health through the Life - course
Dear Ms Elen Ohov,
2019 Country Survey on Capacity and Response to Noncommunicable Diseases
(NCD)
It is my pleasure to invite you to contribute to national data collection
and reporting activity within the framework of the survey. This email
contains information about the content and process of data collection
including access information, the official letter will follow in the
coming days.
The Global Survey on Country Capacity and Response to NCD has been
organized by the Department of Surveillance and Population-based
Prevention of NCDs of WHO Headquarters in collaboration with WHO Regional
Office for Europe since 2000. With this information, WHO aims to support
the countries at the national level regarding NCD strategy and its
implementation, as well as to guide the WHO Member States, WHO and other
partners in required technical assistance and future actions.
Furthermore, the survey provides data for reporting on the Global Action
Plan on NCD, the European Action Plan for the prevention and control of
NCD 2017-2025, the United Nations (UN) 2011 Political Declaration, the UN
General Assembly 2014 and 2018 and WHO 13th Global Programme of Work.
Thus, the results will be presented at the World Health Assembly, the WHO
Regional Committee for Europe, and the UN General Assembly as the
assessment of the WHO Member States meeting their commitments.
The WHO Regional Office for Europe will be responsible for the data
collection within the WHO European Region. As with the previous
iterations, we count on your country reply and commitment on this crucial
occasion. We are particularly proud and grateful that last time all
Member States provided answers, with European Region being the first WHO
Region to achieve 100% response rate and trust that also in this round we
can meet this very high expectation.
Content
The purpose of this regular NCD survey is to gauge your countrys capacity
to respond to NCD, with emphasis on the four main types: cardiovascular
diseases (e.g. heart attacks and stroke), cancers (including the lung,
colon and female breast among others), chronic respiratory diseases (such
as chronic obstructed pulmonary disease and asthma) and diabetes, their
main risk factors (e.g. alcohol consumption, tobacco use, unhealthy
nutrition, obesity, and sedentary lifestyle) and the health system
response (comprising formulating and implementation of policies and
programmes and establishing partnerships across multiple sectors to
address NCD).
We have divided the survey into four modules, each one of them is for
assessing the process and outcome indicators of key aspects of NCD
prevention and control including: public health infrastructure,
partnerships and multisectoral collaboration; policies, strategies and
action plans; health information systems, surveillance and surveys; and,
health system capacity for early detection, treatment and care. By using
a standardized questionnaire we are able to compare country NCD
capacities and responses in the region by certain criteria and to follow
up changes within a defined timescale.
Summary of your country results are included in the regional () and
global (, and ) reports. As you may recognize from the content, the
continuous data provided for the Country Capacity Survey has allowed
obtaining temporal series to monitor the situation and trends in the WHO
Member States.
Process
We will continue using a web-based data collection tool, which will
simplify answering the questionnaire, allowing the automatic monitoring
of questionnaire completion and providing a copy of the set of answers.
This year, in order to facilitate your submission and validation of data,
the tool will include the replies from your country submitted in year
2017.
It will also enable you to upload materials to document evidence required
on certain questions. You may find NCD policy documents submitted for the
2015 and 2017 surveys by your country at the following web site: . For
further reference please find attached the 2019 survey questionnaire.
Please find below the address of the site as well as your countrys login
information:
URL:
Login: EST
Password: ESTB384AE
You may log into the site as many times as needed to access and edit your
countrys questionnaire. While the questions do not need to be answered
in a specific order, it is still very important that it is filled out
completely, including your contact information.
We recommend assigning a single person the responsibility of checking the
completed questionnaire and submitting it to WHO through the site. If
needed, you may share the above login details with colleagues who will be
responsible for completing specific parts of the questionnaire. A PDF-
version of the completed questionnaire can be downloaded from the site
and printed off for review and/or official sign-off, if needed.
Every country traditionally nominated the NCD focal points, who were in
charge of the data collection. Therefore, we kindly request you to either
confirm your role as national survey coordinator or to identify another
person in charge to facilitate the response and interaction, who are able
to find the appropriate professionals with expertise in the topics
covered in the modules, as well as to organize and compile their answers
and ensure the survey completion.
In the latter case, we will appreciate getting the appropriate contact
information, including name, position, postal address, telephone number,
and e-mail address. For the 2017 survey
¾ Sille Pihlak, Chief Specialist, Public Health Department, Ministry
of Social Affairs of Estonia (e-mail: ) was nominated as a focal point.
The deadline for completing the survey is May 10th 2019.
We thank you for undertaking this global project.
Dr Ivo Rakovac, Programme Manager a.i., Surveillance of Noncommunicable
Diseases, Division of Noncommunicable Diseases and Promoting Health
through the Life - Course, is responsible for coordinating the regional
data collection and reporting, and he would appreciate if you could
address your reply to him at eu, tel.: +7 495 787 21 08.
I express my gratitude for your support and collaboration on this
important activity.
Yours sincerely,
Dr Bente Mikkelsen
Director
Division of Noncommunicable Diseases and Promoting Health through the
Life-Course
Enclosures:
NCD CCS questionnaire 2019
WHO | 2019 NCD Country Capacity Assessment English Français Español Português Русский
Glossary Instructions EURO Logout
Country Name
Save Remember to Save before moving to other sections.
Information on those who completed the survey
Who is the focal point for completion of this survey?
Name:
Position:
Contact Information:
Sections Completed:
Name and contact information of others
Sections completed
completing survey
Additional information sources consulted:
Save Remember to Save before moving to other sections.
Save Remember to Save before moving to other sections.
NOTE: For ease of reference, your country’s response to the last round of the Country Capacity Survey for a
particular question can be viewed by hovering over the “2017" button shown next to each question.
I: PUBLIC HEALTH INFRASTRUCTURE, PARTNERSHIPS AND
MULTISECTORAL COLLABORATION FOR NCDs AND THEIR
RISK FACTORS
This module includes questions related to the presence of a unit or division in the ministry
of health dedicated to NCDs and risk factors, staff and funding. It also includes an
assessment of the existence of fiscal interventions as incentives to influence health
behaviour and/or to raise funds for health-related activities. Finally, it assesses the
existence of a formal multisectoral mechanism to coordinate NCD-related activities in
sectors outside of health.
1) Is there a unit/branch/department in the ministry of health or equivalent with responsibility for NCDs
and their risk factors? 2017
Yes No Don't know
IF NO: Go to Question 2
Please provide a copy of an organizational chart indicating where the unit / branch / department
responsible for NCDs is located.
Browse...
1a) Please indicate the number of full-time-equivalent technical/professional staff in the
unit/branch/department. 2017
0
1
2-5
6-10
11 or more
Don't know
1b) Are there technical/professional staff in the unit/branch/ department dedicating a
significant proportion of their time to: new
i) Harmful use of alcohol Yes No Don't know
ii) Unhealthy diet Yes No Don't know
iii) Physical inactivity Yes No Don't know
iv) Tobacco use Yes No Don't know
v) Cancer Yes No Don't know
vi) Cardiovascular diseases Yes No Don't know
vii) Chronic respiratory diseases Yes No Don't know
viii) Diabetes Yes No Don't know
ix) Oral diseases Yes No Don't know
2) Is there dedicated funding allocated in the government budget for the following NCD and risk factor
activities/functions?
i) Primary prevention 2017 Yes No Don't know
ii) Health promotion 2017 Yes No Don't know
iii) Early detection/screening 2017 Yes No Don't know
iv) Health care and treatment 2017 Yes No Don't know
v) Surveillance, monitoring and evaluation 2017 Yes No Don't know
vi) Capacity building 2017 Yes No Don't know
vii) Palliative care 2017 Yes No Don't know
viii) Research 2017 Yes No Don't know
If at least one Yes to above questions:
2a) What are the major sources of regular funding for NCDs and their risk factors?
More than one can apply, rank order them where:
1=Largest source; 2=Next largest; 3=Others
Select 1, 2 or 3 General government revenues 2017
Select 1, 2 or 3 Health insurance 2017
Select 1, 2 or 3 International Donors 2017
Select 1, 2 or 3 National donors 2017
Select 1, 2 or 3 Earmarked taxes on alcohol, tobacco, etc. 2017
Select 1, 2 or 3 Other (specify) 2017 2017
Don't know
3) Is your country implementing any of the following fiscal interventions? (for taxes, please respond
“Yes” only if excise taxes and/or special VAT/sales tax rates are applied)
Taxation on alcoholic beverages 2017 Yes No Don't know
Taxation on tobacco (excise and non-excise taxes)
Yes No Don't know
2017
Taxation on sugar sweetened beverages 2017 Yes No Don't know
Taxation on foods high in fat, sugars or salt 2017 Yes No Don't know
Price subsidies for healthy foods 2017 Yes No Don't know
Taxation incentives to promote physical activity
Yes No Don't know
2017
Others (specify) 2017
Yes No Don't know
2017
Please provide supporting documentation for taxation on sugar sweetened beverages
Browse...
Please provide supporting documentation for taxation on foods high in fat, sugar or salt
Browse...
Please provide supporting documentation for price subsidies for healthy foods
Browse...
Please provide supporting documentation for taxation incentives to promote physical activity
Browse...
If Yes to at least one of the above, other than price subsidies:
3a) Are any of these funds earmarked for health promotion or health service provision? 2017
Yes No Don't know
4) Is there a national multisectoral commission, agency or mechanism to oversee NCD engagement,
policy coherence and accountability of sectors beyond health? 2017
Yes No Don't know
IF NO: Go to MODULE II
Please provide the mandate and a list of members
Browse...
4a) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational or under development:
4b) Please provide name: 2017
4c) Please provide year of establishment: new
4d) Who leads or chairs the commission/agency/mechanisms (provide name): new
4e) Which of the following are members (check all that apply)
Other Government Ministries (non-health, e.g. ministries of sport, education,
transport, urban planning) 2017
United Nations Agencies 2017
Other international institutions 2017
Academia (including research centres) 2017
Nongovernmental organizations / community-based organizations / civil society 2017
Private Sector 2017
Other (specify)
2017 2017
Don't know
IF “Private Sector” is one of the members:
4f) Is the tobacco industry's participation to the consultations and decision making process
excluded from the national multisectoral commission? 2017
Yes No Don't know
Save Remember to Save before moving to other sections. Next
Save Remember to Save before moving to other sections.
NOTE: For ease of reference, your country’s response to the last round of the Country Capacity Survey for a
particular question can be viewed by hovering over the “2017" button shown next to each question.
II: STATUS OF NCD-RELEVANT POLICIES, STRATEGIES, AND
ACTION PLANS
This module includes questions relating to the presence of policies, strategies, or action
plans - the questions differentiate between integrated policies/strategies/action plans that
address several risk factors or diseases, and policies/strategies/action plans that address
a specific disease or risk factor. Additional questions address the existence of specific
policies related to the cost-effective interventions for NCDs.
1a) Are NCDs included in the outcomes or outputs of your current national health plan? 2017
Yes No Don't know
Provide a copy of the national health plan.
Browse...
1b) Are NCDs included in the outcomes or outputs of your current national development agenda?
2017
Yes No Don't know
Provide a copy of the national development agenda.
Browse...
2) Is there a set of time-bound national targets for NCDs based on the 9 voluntary global targets from
the WHO Global Monitoring Framework for NCDs? 2017
Yes No Don't know
Provide a copy of the targets.
Browse...
IF YES:
2a) Is there a set of national indicators for these targets based on the indicators from the WHO
Global Monitoring Framework for NCDs? 2017
Yes No Don't know
Provide a copy of the indicators.
Browse...
II A: INTEGRATED POLICIES, STRATEGIES, AND ACTION PLANS
3) Does your country have a national NCD policy, strategy or action plan which integrates several NCDs
and their risk factors? 2017
Please note that this may be a stand-alone NCD policy, strategy or action plan, or a national health policy, strategy
or action plan where NCDs comprise a significant proportion of the document.
Also note that disease- and risk factor-specific policies, strategies, and action plans will be reported in other
questions later in this module.
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 4
IF YES:
Is it multisectoral? 2017 Yes No Don't know
Is it multi-stakeholder? 2017 Yes No Don't know
Please provide the following information about the policy, strategy or action plan:
3a) Title: 2017
3b) Does it address one or more of the following major risk factors?
Harmful use of alcohol 2017 Yes No Don't know
Unhealthy diet 2017 Yes No Don't know
Physical inactivity 2017 Yes No Don't know
Tobacco 2017 Yes No Don't know
3c) Does it include early detection, treatment and care for:
Cancer 2017 Yes No Don't know
Cardiovascular diseases 2017 Yes No Don't know
Chronic respiratory diseases 2017 Yes No Don't know
Diabetes 2017 Yes No Don't know
3d) Does it include palliative care for patients with NCDs? 2017
Yes No Don't know
3e) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
3e-i) What was the first year of implementation? 2017
3e-ii) What year will it expire? 2017
II B: POLICIES, STRATEGIES, ACTION PLANS FOR SPECIFIC KEY NCDs
The questions in this sub-section only refer to policies, strategies and action plans that
are specific to key NCDs. If your integrated policy, strategy or action plan addresses the
NCD, you do not need to re-enter that information.
4) Is there a policy, strategy, or action plan for cardiovascular diseases in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 5
IF YES:
4a) Write the title 2017
4b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
4b-i) What was the first year of implementation? 2017
4b-ii) What year will it expire? 2017
5) Is there a policy, strategy, or action plan for cancer or some particular cancer types in your country?
2017
Yes for all cancers or cancer in general
Yes but only for specific cancers (specify:) 2017
No
Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 6
IF YES, provide the following for the general cancer policy/strategy/action plan or, if there isn’t
one, for the most important specific cancer policy/strategy/action plan:
5a) Write the title 2017
5b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
5b-i) What was the first year of implementation? 2017
5b-ii) What year will it expire? 2017
6) Is there a policy, strategy, or action plan for diabetes in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 7
IF YES:
6a) Write the title 2017
6b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
6b-i) What was the first year of implementation? 2017
6b-ii) What year will it expire? 2017
7) Is there a policy, strategy, or action plan for chronic respiratory diseases in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 8
IF YES:
7a) Write the title 2017
7b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
7b-i) What was the first year of implementation? 2017
7b-ii) What year will it expire? 2017
8) Is there a policy, strategy, or action plan for oral health in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 9
IF YES:
8a) Write the title 2017
8b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
8b-i) What was the first year of implementation? 2017
8b-ii) What year will it expire? 2017
9) Is there a policy, strategy, or action plan for another non-communicable disease of importance in
your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 10
IF YES:
Please provide the following information about the policy / strategy / action plan. If there
is more than one, please provide the information for the most recent one.
Please specify which NCD: 2017
9a) Write the title 2017
9b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
9b-i) What was the first year of implementation? 2017
9b-ii) What year will it expire? 2017
II C: POLICIES, STRATEGIES, ACTION PLANS FOR NCD RISK FACTORS
The questions in this sub-section only refer to policies, strategies and action plans that
are specific to an NCD risk factor. If your integrated policy, strategy or action plan
addresses the risk factor, you do not need to re-enter that information.
10) Is there a policy, strategy, or action plan for reducing the harmful use of alcohol in your country?
2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 11
IF YES:
10a) Write the title 2017
10b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
10b-i) What was the first year of implementation? 2017
10b-ii) What year will it expire? 2017
11) Is there a policy, strategy, or action plan for reducing overweight / obesity in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 12
IF YES:
11a) Write the title 2017
11b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
11b-i) What was the first year of implementation? 2017
11b-ii) What year will it expire? 2017
12) Is there a policy, strategy, or action plan for reducing physical inactivity and/or promoting physical
activity in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 13
IF YES:
12a) Write the title 2017
12b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
12b-i) What was the first year of implementation? 2017
12b-ii) What year will it expire? 2017
13) Are there national guidelines which provide recommended levels of physical activity for the
population or a specific segment of the population? new
Yes No Don't know
Provide a copy of the guidelines.
Browse...
IF NO: Go to Question 14
IF YES:
13a) Are there guidelines specifically addressing any of the following age groups: new
Children under 5 Yes No Don't know
Children and adolescents (ages 5 – 19) Yes No Don't know
Adults Yes No Don't know
Older adults Yes No Don't know
14) Is there a policy, strategy, or action plan for reducing unhealthy diet related to NCD and/or
promoting a healthy diet in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 15
IF YES:
14a) Write the title 2017
14b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
14b-i) What was the first year of implementation? 2017
14b-ii) What year will it expire? 2017
15) Are there national food-based dietary guidelines for the population or a specific segment of the
population? 2017
Yes No Don't know
Provide a copy of the guidelines.
Browse...
16) Is there a policy, strategy, or action plan to decrease tobacco use in your country? 2017
Yes No Don't know
Provide a copy of the policy, strategy or action plan.
Browse...
IF NO: Go to Question 17
IF YES:
16a) Write the title 2017
16b) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
If Operational:
16b-i) What was the first year of implementation? 2017
16b-ii) What year will it expire? 2017
II D: SELECTED COST-EFFECTIVE POLICIES FOR NCDS AND RELATED RISK
FACTORS
NB: Only selected policies are captured here as information on some policy measures,
e.g. for tobacco and alcohol, are included in other assessment tools.
17) Is there a policy and/or plan on NCD-related research including community-based research and
evaluation of the impact of interventions and policies? 2017
Yes No Don't know
Provide a copy of the policy/plan.
Browse...
IF NO: Go to Question 18
IF YES:
17a) Indicate its stage: 2017
Operational
Under development
Not in effect
Don't know
18) Is there a national network for NCD-related research including community-based research and
evaluation of the impact of interventions and policies? new
Yes No Don't know
Provide any supporting documentation.
Browse...
19) Is your country implementing any policies to reduce the impact on children of marketing of foods
and non-alcoholic beverages high in saturated fatty acids, trans-fatty acids, free sugars, or salt? 2017
Yes No Don't know
Provide a copy of the policy(ies)
Browse...
IF NO: Go to Question 20
IF YES:
19a) Are the policies: 2017
Voluntary
Mandatory
Don't know
19b) Who is responsible for overseeing enforcement and complaints?
Government 2017
Food Industry 2017
Independent regulator 2017
Other, please specify 2017
2017
Don't know 2017
19c) Do they include steps taken to address the effects of cross-border marketing of
food and non-alcoholic beverages on children? 2017
Yes No Don't know
19c-i) If yes, please provide details: 2017
20) Is your country implementing any policies on front-of-pack labelling to identify foods high in
saturated fatty acids, trans-fatty acids, free sugars, or salt? 2017
Yes No Don't know
Provide a copy of the policy(ies)
Browse...
IF NO: Go to Question 21
IF YES:
20a) Are the policies:
Voluntary
Mandatory
Don't know
20b) Who is responsible for overseeing enforcement and complaints?
Government
Food Industry
Other, please specify
Don't know
21) Is your country implementing any national policies to reduce population saturated fatty acid intake
? 2017
Yes No Don't know
Provide a copy of the policy(ies)
Browse...
IF NO: Go to Question 22
21a) If yes, are the policies:
Voluntary
Mandatory
Don't know
22) Is your country implementing any national policies to eliminate industrially produced trans-fatty
acids (i.e. partially hydrogenated oils) in the food supply? 2017
Yes No Don't know
Provide a copy of the policy(ies)
Browse...
IF NO: Go to Question 23
22a) If yes, are the policies:
Voluntary
Mandatory
Don't know
23) Is your country implementing any policies to reduce population salt/sodium consumption? 2017
Yes No Don't know
Provide a copy of the policy(ies)
Browse...
IF NO: Go to Question 24
IF YES:
23a) Are these targeted at:
Product reformulation by industry across the food supply
Yes No Don't know
2017
Regulation of salt content of food served in specific
Yes No Don't know
settings such as hospitals, schools, workplaces 2017
Public awareness programme 2017 Yes No Don't know
Front-of-pack nutrition labeling 2017 Yes No Don't know
23b) If yes to product reformulation or regulation of salt/sodium content, is the policy:
2017
Voluntary
Mandatory
Don't know
24) Has your country implemented any national public education and awareness campaign on diet
within the past 2 years? 2017
Yes No Don't know
Provide any documentation of the campaign and/or a link to the campaign website, if available
Browse...
IF NO: Go to Question 25
24a) If yes, please provide details of the public education and awareness campaign(s):
2017
25) Has your country implemented any national public education and awareness campaign on physical
activity within the past 2 years? 2017
Yes No Don't know
Provide any documentation of the campaign and/or a link to the campaign website, if available
Browse...
IF NO: Go to Question 26
IF YES:
25a) Does the campaign integrate with community-based programmes? new
Yes No Don't know
25b) Is the campaign supported by any environmental changes to enable physical
activity? new
Yes No Don't know
25c) Does the campaign address any of the social, environmental and economic benefits
of physical activity, in addition to the health benefits? new
Yes No Don't know
25d) Please provide details of the public education and awareness campaign(s): 2017
26) Has your country implemented any national or subnational mass participation events to encourage
participation by the general public in free opportunities for physical activity within the past 2 years?
Examples of mass participation events include national walk to school days/weeks; other free events; cycling,
yoga, tai chi, dance. Note this does NOT include hosting of major competitive sporting events like marathons,
which require paid participation. new
Yes No Don't know
Provide any documentation of the events and/or links to event websites, if available
Browse...
IF NO: Go to Question 27
26a) Please provide details of the event(s):
27) Has your country implemented any national, NCD-related mHealth initiatives, such as tobacco
cessation, hypertension management, cervical cancer screening awareness, promotion of physical
activity, within the past 2 years? new
Yes No Don't know
Provide any documentation of the mHealth initiative(s)
Browse...
IF NO: Go to MODULE III
27a) Please provide details of the mHealth initiative(s):
Save Remember to Save before moving to other sections. Previous Next
Save Remember to Save before moving to other sections.
NOTE: For ease of reference, your country’s response to the last round of the Country Capacity Survey for a
particular question can be viewed by hovering over the “2017" button shown next to each question.
III: HEALTH INFORMATION SYSTEMS, MONITORING,
SURVEILLANCE AND SURVEYS FOR NCDs AND THEIR RISK
FACTORS
The questions in this module assess surveillance relating to the mortality, morbidity and
risk factor reporting systems of each country and whether NCD mortality, morbidity and risk
factor data were included in their national health reporting systems.
1) In your country, who has responsibility for surveillance of NCDs and their risk factors? 2017
An office/department/administrative division within the MOH exclusively dedicated to
NCD surveillance
An office/department/administrative division within the MOH not exclusively
dedicated to NCD surveillance
Responsibility is shared across several offices/departments/administrative divisions
within the MOH
Coordination is by an external agency, such as an NGO or statistical organization
No one has this responsibility
Don't know
III A: DATA INCLUDED IN THE NATIONAL HEALTH INFORMATION SYSTEM
(National health information system refers to the annual or regular reporting system of the
National Statistical Office or Ministry of Health)
2) Does your country have a system for collecting mortality data by cause of death on a routine basis?
2017
Yes No Don't know
IF NO: Go to Question 3
IF YES:
2a) Is there a civil/vital registration system? 2017 Yes No Don't know
2b) Is there a sample registration system? 2017 Yes No Don't know
2c) What is the latest year for which data are available? 2017
2d) What percentage of total deaths in the entire country are officially registered in the system?
(national estimated completeness) new
<20%
20-49%
50-74%
75% or more
Don't know
If estimated completeness is known:
2di) Specify source of estimated completeness: new
2dii) If applicable, specify any population/area not covered by your registration system:
new
Not applicable
Don't know
3) Does your country have a cancer registry? 2017
Yes No Don't know
IF NO: Go to Question 4
IF YES:
3a) Are the data collected population-based, hospital-based, or other? 2017
Population-based
Hospital-based
Other (specify)
Don't know
3b) Is the coverage of the registry national or subnational? 2017
National (covers the whole population of the country)
Subnational (covers only the population of a defined region, not the whole
country)
Don't know
3c) What is the latest year for which data are available? 2017
4) Does your country have a diabetes registry? 2017
Yes No Don't know
IF NO: Go to Question 5
IF YES:
4a) Are the data collected population-based, hospital-based, or other? 2017
Population-based
Hospital-based
Other (specify) 2017
Don't know
4b) Is the coverage of the registry national or subnational? 2017
National (covers the whole population of the country)
Subnational (covers only the population of a defined region, not the whole
country)
Don't know
4c) Does the registry include data on any chronic complications which are updated as the patient’s
complications status changes? 2017
Yes No Don't know
4d) What is the latest year for which data are available? 2017
5) Does your country have a system for recording patient information that includes NCD status (e.g.
hypertension, diabetes, tobacco use status)? 2017
Yes No Don't know
IF NO: Go to Question 6
IF YES:
5a) Is it an electronic medical records/health records system? 2017
Yes No Don't know
5b) What is the coverage of the system? 2017
National (covers the whole population of the country)
Subnational (covers only the population of a defined region, not the whole
country)
Don't know
6) Has your country conducted a survey of facilities to assess service availability and readiness for
NCDs? 2017
Yes No Don't know
IF NO: Go to Question 7
Please provide a copy of the survey report
Browse...
6a) Year of last survey 2017
6b) Coverage of last survey: 2017
National
Subnational
Don't know
III B: RISK FACTOR SURVEILLANCE
7) Have population-based surveys of risk factors (may be a single RF or multiple) been conducted in
your country for any of the following:
For the questions on surveys on adolescents or children, please include here only surveys specifically targeting
adolescents or children (i.e. do not repeat adult surveys that may have covered part of the adolescent or child age
range).
Please provide a copy of the survey report(s)
Browse...
7a) Harmful alcohol use
Yes No Don't know 2017
IF NO: Go to Question 7b
IF YES: IF YES:
i) Was there a survey on adolescents? 2017 ii) Was there a survey on adults? 2017
Yes No Don't know Yes No Don't know
IF YES: IF YES:
i-1) Was it: 2017 ii-1) Was it: 2017
National National
Subnational Subnational
Don't know Don't know
i-2) How often is the survey conducted? 2017 ii-2) How often is the survey conducted? 2017
Ad hoc Ad hoc
Every 1 to 2 years Every 1 to 2 years
Every 3 to 5 years Every 3 to 5 years
Other Other
Don't know Don't know
i-3) When was the last survey conducted? (give ii-3) When was the last survey conducted? (give
year) 2017 year) 2017
7b) Unhealthy diet
Yes No Don't know 2017
IF NO: Go to Question 7c
IF YES: IF YES:
i) Was there a survey on adolescents? 2017 ii) Was there a survey on adults? 2017
Yes No Don't know Yes No Don't know
IF YES: IF YES:
i-1) Was it: new ii-1) Was it: new
24 hour recall 24 hour recall
Food frequency Food frequency
Other Other
Don't know Don't know
i-2) Was it: 2017 ii-2) Was it: 2017
National National
Subnational Subnational
Don't know Don't know
i-3) How often is the survey conducted? 2017 ii-3) How often is the survey conducted? 2017
Ad hoc Ad hoc
Every 1 to 2 years Every 1 to 2 years
Every 3 to 5 years Every 3 to 5 years
Other Other
Don't know Don't know
i-4) When was the last survey conducted? (give ii-4) When was the last survey conducted? (give
year) 2017 year) 2017
7c) Physical inactivity
Yes No Don't know 2017
IF NO: Go to Question 7d
IF YES: IF YES:
i) Was there a survey on children? new ii) Was there a survey on adolescents? 2017
Yes No Don't know Yes No Don't know
IF YES: IF YES:
i-1) Was it: ii-1) Was it: 2017
Measured Measured
Self-reported Self-reported
Don't know Don't know
i-2) Was it: ii-2) Was it: 2017
National
National
Subnational
Subnational
Don't know
Don't know
i-3) How often is the survey conducted?
ii-3) How often is the survey conducted? 2017
Ad hoc
Ad hoc
Every 1 to 2 years
Every 1 to 2 years
Every 3 to 5 years
Every 3 to 5 years
Other
Other
Don't know
Don't know
i-4) When was the last survey conducted? (give
ii-4) When was the last survey conducted? (give
year)
year) 2017
IF YES:
iii) Was there a survey on adults? 2017
Yes No Don't know
IF YES:
iii-1) Was it: 2017
Measured
Self-reported
Don't know
iii-2) Did it assess physical activity for work/in the
household, for transport and during leisure time?
2017
Yes No Don't know
iii-3) Was it: 2017
National
Subnational
Don't know
iii-4) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iii-5) When was the last survey conducted? (give
year) 2017
7d) Tobacco use
Yes No Don't know 2017
IF NO: Go to Question 7e
IF YES: IF YES:
i) Was there a survey on adolescents? 2017 ii) Was there a survey on adults? 2017
Yes No Don't know Yes No Don't know
IF YES: IF YES:
i-1) Was it: 2017 ii-1) Was it: 2017
National National
Subnational Subnational
Don't know Don't know
i-2) How often is the survey conducted? 2017 ii-2) How often is the survey conducted? 2017
Ad hoc Ad hoc
Every 1 to 2 years Every 1 to 2 years
Every 3 to 5 years Every 3 to 5 years
Other Other
Don't know Don't know
i-3) When was the last survey conducted? (give ii-3) When was the last survey conducted? (give
year) 2017 year) 2017
7e) Raised blood glucose/diabetes
Yes No Don't know 2017
IF NO: Go to Question 7f
IF YES:
i) Was it: 2017
Measured
Self-reported
Don't know
ii) Was it: 2017
National
Subnational
Don't know
iii) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iv) When was the last survey conducted? (give year) 2017
7f) Raised total cholesterol
Yes No Don't know 2017
IF NO: Go to Question 7g
IF YES:
i) Was it: 2017
Measured
Self-reported
Don't know
ii) Was it: 2017
National
Subnational
Don't know
iii) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iv) When was the last survey conducted? (give year) 2017
7g) Raised blood pressure/Hypertension
Yes No Don't know 2017
IF NO: Go to Question 7h
IF YES:
i) Was it: 2017
Measured
Self-reported
Don't know
ii) Was it: 2017
National
Subnational
Don't know
iii) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iv) When was the last survey conducted? (give year) 2017
7h) Overweight and obesity
Yes No Don't know 2017
IF NO: Go to Question 7i
IF YES: IF YES:
i) Was there a survey on children? new ii) Was there a survey on adolescents? 2017
Yes No Don't know Yes No Don't know
IF YES: IF YES:
i-1) Was it: ii-1) Was it: 2017
Measured Measured
Self-reported Self-reported
Don't know Don't know
i-2) Was it: ii-2) Was it: 2017
National
National
Subnational
Subnational
Don't know
Don't know
i-3) How often is the survey conducted?
ii-3) How often is the survey conducted? 2017
Ad hoc
Ad hoc
Every 1 to 2 years
Every 1 to 2 years
Every 3 to 5 years
Every 3 to 5 years
Other
Other
Don't know
Don't know
i-4) When was the last survey conducted? (give
ii-4) When was the last survey conducted? (give
year)
year) 2017
IF YES:
iii) Was there a survey on adults? 2017
Yes No Don't know
IF YES:
iii-1) Was it: 2017
Measured
Self-reported
Don't know
iii-2) Was it: 2017
National
Subnational
Don't know
iii-3) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iii-4) When was the last survey conducted? (give
year) 2017
7i) Salt/Sodium intake
Yes No Don't know 2017
IF NO: Go to MODULE IV
IF YES:
i) Was it: 2017
Measured by 24-hr urine collection
Measured by 12-hr urine collection
Measured by spot urine collection
Measured by combination of urine collection methods
Self-reported salt intake
Don't know
ii) Was it: 2017
National
Subnational
Don't know
iii) How often is the survey conducted? 2017
Ad hoc
Every 1 to 2 years
Every 3 to 5 years
Other
Don't know
iv) When was the last survey conducted? (give year) 2017
Save Remember to Save before moving to other sections. Previous Next
Save Remember to Save before moving to other sections.
NOTE: For ease of reference, your country’s response to the last round of the Country Capacity Survey for a
particular question can be viewed by hovering over the “2017" button shown next to each question.
IV: CAPACITY FOR NCD EARLY DETECTION, TREATMENT AND
CARE WITHIN THE HEALTH SYSTEM
The questions in this module assess the health care systems capacity related to NCD
early detection, treatment and care within the health care sector. Specific questions focus
on availability of guidelines or protocols to treat major NCDs, and the tests, procedures
and equipment related to NCDs within the health-care system. It also assesses the
availability of palliative care services for NCDs.
1a) Please indicate whether evidence-based national guidelines/protocols/standards are available for
the management (diagnosis and treatment) of each of the major NCDs through a primary care approach
recognized/approved by government or competent authorities. Where guidelines/protocols/standards
are available, please indicate their implementation status, when they were last updated and whether
they contain standard criteria for the referral of patients from primary care to a higher level of care
(secondary/tertiary).
Cardiovascular Diabetes Cancer Chronic Respiratory
Disease Disease
i) Are they Yes Yes
available? Yes (specify topics covered) No Yes (specify cancer types) No
Don't know Don't know
new 2017 2017 2017
No No
Don't know Don't know
2017 2017
ii) Do they Yes Yes Yes Yes
include No No No No
drug- and
Don't know Don't know Don't know Don't know
dose-
If Yes: If there are If Yes: If there are If Yes: If there are
specific
multiple guidelines, multiple guidelines, multiple guidelines,
protocols?
specify for which specify for which specify for which
new
conditions: conditions: conditions:
iii) Are they Yes Yes Yes Yes
being No No No No
utilized in
Don't know Don't know Don't know Don't know
at least
50% of 2017 2017 2017 2017
health care
facilities?
iv) When
were they
2017 2017 2017 2017
last
updated?
v) Do they Yes Yes Yes Yes
include No No No No
referral
Don't know Don't know Don't know Don't know
criteria?
2017 2017 2017 2017
Please provide a copy of the cardiovascular disease Browse...
guideline(s)
Please provide a copy of the diabetes guideline(s) Browse...
Please provide a copy of the cancer guideline(s) Browse...
Please provide a copy of the chronic respiratory disease Browse...
guideline(s)
1b) Please indicate whether evidence-based national guidelines/protocols/standards are available for
the management of each of the following NCD risk factors through a primary care approach
recognized/approved by government or competent authorities. new
Alcohol Tobacco Overweight/obesity Physical
dependence dependence inactivity
i) Are they available? Yes Yes Yes Yes
No No No No
Don't know Don't know Don't know Don't know
ii) Are they being utilized Yes Yes Yes Yes
in at least 50% of health No No No No
care facilities?
Don't know Don't know Don't know Don't know
iii) When were they last
updated?
iv) Do they include Yes Yes Yes Yes
referral criteria? No No No No
Don't know Don't know Don't know Don't know
Please provide a copy of the alcohol dependence Browse...
guideline(s)
Please provide a copy of the tobacco dependence Browse...
guideline(s)
Please provide a copy of the overweight/obesity Browse...
guideline(s)
Please provide a copy of the physical inactivity Browse...
guideline(s)
2) Indicate the availability of the following basic technologies for early detection, diagnosis /
monitoring of NCDs in the primary care facilities of the public and private health sector where:
Generally available=1, Generally not available = 2, Don't know = 3
Availability in the Availability in the
* Generally available: in 50% or more health care facilities primary care facilities primary care facilities
Generally not available: in less than 50% health care facilities
of the public health of the private health
sector (1, 2, or 3) sector (1, 2, or 3)
Overweight and obesity
2a) Measuring of weight 1, 2, 3 2017 1, 2, 3 2017
2b) Measuring of height 1, 2, 3 2017 1, 2, 3 2017
Diabetes mellitus
2c) Blood glucose measurement 1, 2, 3 2017 1, 2, 3 2017
2d) Oral glucose tolerance test 1, 2, 3 2017 1, 2, 3 2017
2e) HbA1c test 1, 2, 3 2017 1, 2, 3 2017
2f) Dilated fundus examination 1, 2, 3 2017 1, 2, 3 2017
2g) Foot vibration perception by tuning fork 1, 2, 3 2017 1, 2, 3 2017
2h) Urine strips for glucose and ketone measurement 1, 2, 3 2017 1, 2, 3 2017
Cardiovascular disease
2i) Blood pressure measurement 1, 2, 3 2017 1, 2, 3 2017
2j) Total cholesterol measurement 1, 2, 3 2017 1, 2, 3 2017
2k) Urine strips for albumin assay 1, 2, 3 2017 1, 2, 3 2017
Asthma and chronic obstructive pulmonary disease
2l) Peak flow measurement spirometry 1, 2, 3 2017 1, 2, 3 2017
3) Please indicate if there is a national screening program targeting the general population for the following cancers
and, if yes, provide details.
Please provide a copy of the screening program strategy and/or the last report on the screening program.
Browse...
Cancers Initial screening Population targeted Type of program Screening
method (indicate by the program coverage
only one, the most
widely used)
Breast Clinical breast exam Women aged Organised population- Less than 10%
based screening
Yes to 10% to 50%
Opportunistic screening
No Mammography screening Other, specify: more than 50%
Don't know but less than 70%
Don't know Don't know
2017 70% or more
Don't know
2017 2017
Don't know
IF NO: Go to next row 2017
Cervix Visual inspection Women aged Organised population- Less than 10%
based screening
Yes PAP smear to 10% to 50%
Opportunistic screening
No HPV Test Other, specify: more than 50%
Don't know but less than 70%
Don't know Don't know
2017 70% or more
Don't know
2017 2017
Don't know
IF NO: Go to next row 2017
Colon People aged Organised population-
Faecal test Less than 10%
based screening
Yes Colonoscopy/ to 10% to 50%
sigmoidoscopy Opportunistic screening
No Other, specify: more than 50%
Don't know Don't know but less than 70%
Don't know
2017 2017 70% or more
Don't know
2017
Don't know
IF NO: Go to next row 2017
Other cancer type(s)
Specify:
2017
Yes
No
Don't know
2017 2017 2017 2017
2017
4) Please indicate if early detection of the following cancers by means of rapid identification of the first
symptoms is integrated into primary health care services and if there is a clearly defined referral
system from primary care to secondary / tertiary care for suspect cases (in low- and middle-income
countries this set of measures may be designated as an 'early diagnosis' programme):
Please provide a copy of the strategy relative to early detection.
Browse...
Breast Cervix Colon Cancers in Other cancer
Children, specify: type(s) -
specify:
new
2017
Program/guidelines Yes Yes Yes Yes Yes
to strengthen early No No No No No
detection of first
Don't know Don't know
symptoms at primary
Don't know Don't know Don't know
health care level 2017
2017 2017 2017
Clearly defined Yes Yes Yes Yes Yes
referral system from No No No No No
primary care to
Don't know Don't know
secondary and
Don't know Don't know Don't know
tertiary care new 2017
2017 2017 2017
5) Is HPV vaccination included in the national immunization schedule? new
Yes No Don't know
IF NO: Go to Question 6
5a) What was the HPV vaccine coverage (last dose) in the last calendar year?
Less than 10%
10% to 50%
more than 50% but less than 80%
80% or more
Don't know
6) Describe the availability of the medicines below in the primary care facilities of the public health
sector, where: Generally available=1; Generally not available = 2, Don't know = 3.
* Generally available: in 50% or more pharmacies
Generally not available: in less than 50% of pharmacies
Generic drug name Availability*
6a) Insulin 1, 2, 3
2017
6b) Aspirin (75/100 mg) 1, 2, 3
2017
6c) Metformin 1, 2, 3
2017
6d) Thiazide Diuretics 1, 2, 3
2017
6e) ACE Inhibitors 1, 2, 3
2017
6f) Angiotensin II receptor blockers (ARBs) 1, 2, 3
new
6g) Calcium channel Blockers 1, 2, 3
2017
6h) Beta Blockers 1, 2, 3
2017
6i) Statins 1, 2, 3
2017
6j) Oral morphine 1, 2, 3
2017
6k) Steroid inhaler 1, 2, 3
2017
6l) Bronchodilator 1, 2, 3
2017
6m) Sulphonylurea(s) 1, 2, 3
2017
6n) Benzathine penicillin injection 1, 2, 3
2017
6o) Nicotine Replacement Therapy 1, 2, 3
2017
7) Indicate the availability* of the following procedures for treating NCDs in the publicly funded health
system, where:
1=Generally available; 2=Generally not available; 3=Don't know
* Generally available: reaches 50% or more patients in need
Generally not available: reaches less than 50% of patients in need
Procedure name Availability
7a) Retinal photocoagulation 1, 2, 3
2017
7b) Renal replacement therapy by dialysis 1, 2, 3
2017
7c) Renal replacement by transplantation 1, 2, 3
2017
7d) Coronary bypass 1, 2, 3
2017
7e) Coronary stenting 1, 2, 3
2017
7f) Thrombolytic therapy (streptokinase) 1, 2, 3
for acute myocardial infarction 2017
7g) Bone marrow transplantation 1, 2, 3
new
8) Detail the availability of cancer diagnosis and treatment services in the public sector:
* Generally available: reaches 50% or more patients in need
Generally not available: reaches less than 50% of patients in need
Service Availability*
Cancer centres or cancer Generally available
departments at tertiary level 2017 Generally not available
Don't know
Pathology services (laboratories) Generally available
2017 Generally not available
Don't know
Cancer surgery 2017 Generally available
Generally not available
Don't know
Chemotherapy 2017 Generally available
Generally not available
Don't know
Radiotherapy 2017 Generally available
Generally not available
Don't know
9) How many dedicated cancer centres are there in the country? new
Dedicated cancer centres are defined as providing multi-disciplinary care including pathology, surgery, systematic
therapy, and radiotherapy. If you don’t know the exact number, please give an estimated range.
Number of public cancer centres: Don't know
Number of private cancer centres: Don't know
10) Indicate the availability* of palliative care for patients with NCD in the public health system:
* Generally available: reaches 50% or more patients in need
Generally not available: reaches less than 50% of patients in need
10a) In primary health care facilities: 2017
Generally available
Generally not available
Don't know
10b) In community or home-based care: 2017
Generally available
Generally not available
Don't know
11) What proportion of primary health care facilities are offering cardiovascular risk stratification for
the management of patients at high risk for heart attack and stroke? 2017
None
Less than 25%
25% to 50%
More than 50%
Don't know
If more than none:
11a) Which CVD risk scoring chart is used? 2017
Tablas de predicción del riesgo de la OMS/SIH
Other (specify) 2017
Don't know
12) Indicate the availability* of services for stroke in the public health system:
* Generally available: reaches 50% or more patients in need
Generally not available: reaches less than 50% of patients in need
12a) Provision of care for acute stroke: 2017
Generally available
Generally not available
Don't know
12b) Rehabilitation for stroke patients: 2017
Generally available
Generally not available
Don't know
13) Is there a register of patients who have had rheumatic fever and rheumatic heart disease? 2017
Yes No Don't know
IF YES:
13a) Are there systems for follow-up/recall to deliver long-term penicillin
prophylaxis? 2017
Yes No Don't know
Save Remember to Save before moving to other sections. Previous Next